Reaction Biology Announces Appointment of Richard S. Kollender to Chief Financial Officer and Chief Business Officer | News

MALVERN, Pa., April 4, 2022 /PRNewswire/ — Response Biology (“Response” or the “Company”), an sector-foremost service provider of drug discovery companies, nowadays declared the appointment of Richard S. Kollender to the positions of Chief Financial Officer (CFO), Chief Small business Officer (CBO) and member of the Government Committee, productive right away, to further bolster the management group and assist the Company’s next phase of development.

“We are thrilled to welcome Prosperous, a seasoned health care finance and functions government, to the Government Committee of Response Biology,” claimed John H. Johnson, Chief Executive Officer and Director of Reaction Biology.  “Possessing managed huge, world wide biopharmaceutical and lifestyle sciences companies in excess of the class of his vocation, Rich brings priceless expertise and insights to Response in our Firm’s evolution as a planet chief in drug discovery providers.”

Mr. Kollender has a lot more than 30 many years of practical experience in the healthcare sector. Prior to joining Reaction Biology, he served as Strongbridge BioPharma’s President and Chief Economic Officer and was dependable for strengthening the company’s monetary place and footprint as a profitable exceptional ailment organization right up until it was obtained by Xeris Biopharma, Inc., in Oct 2021. From 2003, he served to start with as a Principal and then as Companion of Quaker Associates Management, LP, a health care expense firm. In addition, from August 2016 through September 2018, he served as Chief Business enterprise Officer and Chief Monetary Officer of Speedy Micro Biosystems, a Quaker Partners’ portfolio company, where by he performed a essential purpose in the business enterprise enlargement and adoption of the company’s Development Direct™ System. Earlier, he held positions in profits, marketing and advertising, and globally business improvement at GlaxoSmithKline (GSK) and served as expense manager at its company enterprise capital arm, S.R. One. He started his career as a Accredited Community Accountant, in the beginning with KPMG. He at this time serves as Chairman of the Board of Directors for Restorative Therapies. He also serves on the Board of Administrators for Immediate Micro Biosystems (NASDAQ: RPID) and as an adjunct faculty member at Lehigh College. He beforehand served on the Board of Directors of Strongbridge BioPharma, Insmed, NuPathe, Inc., and Celator Pharmaceuticals, Inc., in addition to various other privately held businesses. He holds an MBA and a certification diploma in the graduate application in wellness administration and coverage, the two from the University of Chicago and a B.A. in accounting from Franklin and Marshall University.

“Response Biology is getting into a pivotal stage in its development as a favored partner to biopharmaceutical firms in the fascinating and ever-changing space of drug discovery,” mentioned Richard S. Kollender. “I glance ahead to drawing from my corporate finance and organization operations practical experience to produce worth to our customers, as very well as the company and client communities who seek safe and efficient therapeutic improvements.”

About Response Biology

Launched in 2001, Response is a agreement investigate organization (CRO) that presents a total suite of drug discovery companies to more than 1,800 biopharmaceutical customers globally. Reaction’s abilities involve purposeful biochemical assays, compound screening, a huge array of mechanistic and biophysical research, and an comprehensive array of mobile-based assays. Response maintains 1 of the greatest panels of kinase assays in the planet with around 750 special assays. The Firm performs about 5,000 consumer jobs yearly with its around 2,000 validated assays.  The Firm has lab facilities in Malvern, PA, and Freiburg, Germany, with approximately 130 staff.

Call:

Elixir Overall health General public Relations

Lindsay Rocco

+1 862-596-1304

[email protected]

Cision Perspective authentic written content:https://www.prnewswire.com/news-releases/reaction-biology-announces-appointment-of-richard-s-kollender-to-chief-monetary-officer-and-chief-business enterprise-officer-301516568.html

Resource Response Biology